TRxADE HEALTH, INC. Files Form 10-K/A Amendment

TL;DR

<b>TRxADE HEALTH, INC. has filed an amendment to its 2023 annual report, confirming compliance with SEC filing requirements.</b>

AI Summary

TRxADE HEALTH, INC (SCNX) filed a Amended Annual Report (10-K/A) with the SEC on May 3, 2024. TRxADE HEALTH, INC. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2023. The company is incorporated in Delaware and its principal executive offices are located in Lutz, Florida. TRxADE HEALTH, INC. is registered under the ticker symbol MEDS on The NASDAQ Stock Market LLC. The filing confirms the company has filed all required reports for the preceding 12 months and has been subject to filing requirements for the past 90 days. The company has submitted all Interactive Data Files required by Rule 405 of Regulation S-T during the preceding 12 months.

Why It Matters

For investors and stakeholders tracking TRxADE HEALTH, INC, this filing contains several important signals. This amendment indicates a procedural update or correction to the company's financial reporting, which could impact investor confidence and regulatory standing. The confirmation of consistent filing suggests ongoing operational stability and adherence to disclosure obligations, crucial for maintaining market trust.

Risk Assessment

Risk Level: low — TRxADE HEALTH, INC shows low risk based on this filing. The filing is a routine amendment (10-K/A) and does not contain new financial data or significant disclosures that would alter the company's risk profile.

Analyst Insight

Monitor future filings for any substantive changes or updates that may arise from this amendment.

Key Numbers

• 2023-12-31 — Fiscal Year End (The report covers the fiscal year ended on this date.)
• 2024-05-03 — Filing Date (The date the 10-K/A amendment was filed.)
• MEDS — Trading Symbol (The stock ticker for TRxADE HEALTH, INC.)
• 001-39199 — Commission File Number (SEC file number assigned to the company.)

Key Players & Entities

• TRxADE HEALTH, INC. (company) — Filer name and subject of the filing.
• MEDS (company) — Trading symbol for TRxADE HEALTH, INC. common stock.
• The NASDAQ Stock Market LLC (company) — Exchange where MEDS is traded.
• 2023-12-31 (date) — Fiscal year end date for the report.
• 2024-05-03 (date) — Filing date of the amendment.
• Delaware (jurisdiction) — State of incorporation for TRxADE HEALTH, INC.
• Lutz, Florida (location) — Location of the company's principal executive offices.
• 001-39199 (other) — Commission File Number for TRxADE HEALTH, INC.

FAQ

Industry Context

TRxADE HEALTH, INC. operates in the wholesale drug and druggists' sundries sector. This filing is a routine amendment to its annual report.

Regulatory Implications

The company is subject to the reporting requirements of the Securities Exchange Act of 1934, including filing annual reports (10-K) and amendments.

What Investors Should Do

1. Review the full 10-K/A filing for any specific details or corrections made in the amendment.
2. Track future SEC filings from TRxADE HEALTH, INC. for any new financial or operational information.
3. Assess the company's compliance history and adherence to regulatory deadlines.

Key Dates

• 2023-12-31: Fiscal Year End — Marks the end of the reporting period for the annual report.
• 2024-05-03: Filing Date — Date the 10-K/A amendment was submitted to the SEC.

Year-Over-Year Comparison

This is an amendment (10-K/A) to the previously filed annual report for the fiscal year ended December 31, 2023. It primarily serves to update or correct information rather than present new annual results.

Key Financial Figures

• $0.00001 — nge on which registered Common Stock, $0.00001 Par Value Per Share MEDS The NASDAQ

Filing Documents

• form10-ka.htm (10-K/A) — 480KB
• ex31-3.htm (EX-31.3) — 6KB
• ex31-4.htm (EX-31.4) — 6KB
• ex97-1.htm (EX-97.1) — 35KB
• 0001493152-24-017778.txt (&nbsp;) — 812KB
• meds-20231231.xsd (EX-101.SCH) — 3KB
• meds-20231231_lab.xml (EX-101.LAB) — 36KB
• meds-20231231_pre.xml (EX-101.PRE) — 24KB
• form10-ka_htm.xml (XML) — 8KB

Executive Compensation

Executive Compensation 10 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 18 Item 13. Certain Relationships and Related Transactions, and Director Independence 21 Item 14. Principal Accountant Fees and Services 22 PART IV Item 15. Exhibits, Financial Statements and Schedules 23

Signatures

Signatures 26 3 CAUTIONARY This Form 10-K/A contains statements that constitute forward-looking statements which are subject to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Some of the statements in this Form 10-K/A constitute forward-looking statements because they relate to future events or our future performance or future financial condition. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our company, our industry, our beliefs and our assumptions. Our forward-looking statements include, but are not limited to, statements regarding our or our management team's expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: " anticipate ," " believe ," " continue ," " could ," " estimate ," " expect ," " intend ," " may ," " ongoing, " " plan ," " potential ," " predict ," " project ," " should ," or the negative of these terms or other similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These factors include those set forth below and those disclosed under " Risk Factors " in the Original Filing. Forward-looking Risks related to our history of operating losses and that our operations may not become profitable; Claims relating to alleged violati

View Full Filing

View this 10-K/A filing on SEC EDGAR